Rianne EllenbroekPrinciple at BGV (BioGeneration Ventures)Speaker
Rianne Ellenbroek is Principal at BGV and joined the company in 2020 as Investment Manager of BGV's pre-seed fund FIRST where she led investments in TargED Biopharmaceuticals, River Biomedics, Phlox Therapeutics and Phosphoenix. Prior to joining BGV, she was an Associate at INKEF Capital. Rianne is a medical biologist by training. She obtained her PhD at Leiden University that was focused on regenerative medicine for metabolic diseases, while performing part of her activities at biotech company Galapagos. Winning a grant facilitated her to take a position as postdoctoral fellow at the Kovler Diabetes Center at the University of Chicago. Next to performing her research, she was a fellow at the university’s Technology Transfer Office which has sparked her interest in the early stages of life sciences ventures.